Next-generation Sequencing (NGS) Diagnostics Market - Strategic Insights and Forecasts (2026-2031)

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

1. 2.1. Market Overview

2. 2.2. Market Definition

3. 2.3. Scope of the Study

4. 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

1. 3.1. Market Drivers

2. 3.2. Market Restraints

3. 3.3. Market Opportunities

4. 3.4. Porter’s Five Forces Analysis

5. 3.5. Industry Value Chain Analysis

6. 3.6. Policies and Regulations

7. 3.7. Strategic Recommendations

8. 3.8. Product Pipeline Analysis

9. 3.9. Incidence and Prevalence Analysis

10. 3.10. Patent Analysis

4. TECHNOLOGICAL OUTLOOK

5. NEXT-GENERATION SEQUENCING (NGS) DIAGNOSTICS MARKET BY COMPONENT TYPE

1. 5.1. Introduction

2. 5.2 Instruments

3. 5.3. Reagents & Kits

4. 5.4. Software & Services

6. NEXT-GENERATION SEQUENCING (NGS) DIAGNOSTICS MARKET BY TECHNOLOGY

1. 6.1. Introduction

2. 6.2. Whole Genome Sequencing

3. 6.3 Whole Exome Sequencing

4. 6.4 Targeted Sequencing

5. 6.5 RNA Sequencing

7. NEXT-GENERATION SEQUENCING (NGS) DIAGNOSTICS MARKET BY APPLICATION

1. 7.1. Introduction

2. 7.2. Oncology

3. 7.3. Infectious Diseases

4. 7.4. Genetic Disorders

5. 7.5. Reproductive Health

6. 7.6. Pharmacogenomics

8. NEXT-GENERATION SEQUENCING (NGS) DIAGNOSTICS MARKET BY GEOGRAPHY

1. 8.1. Introduction

2. 8.2. North America

   1. 8.2.1. USA

   2. 8.2.2. Canada

   3. 8.2.3. Mexico

3. 8.3. South America

   1. 8.3.1. Brazil

   2. 8.3.2. Argentina

   3. 8.3.3. Others

4. 8.4. Europe

   1. 8.4.1. United Kingdom

   2. 8.4.2. Germany

   3. 8.4.3. France

   4. 8.4.4. Spain

   5. 8.4.5. Others

5. 8.5. Middle East and Africa

   1. 8.5.1. Saudi Arabia

   2. 8.5.2. UAE

   3. 8.5.3. Others

6. 8.6. Asia Pacific

   1. 8.6.1. China

   2. 8.6.2. India

   3. 8.6.3. Japan

   4. 8.6.4. South Korea

   5. 8.6.5. Indonesia

   6. 8.6.6. Thailand

   7. 8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

1. 9.1. Major Players and Strategy Analysis

2. 9.2. Market Share Analysis

3. 9.3. Mergers, Acquisitions, Agreements, and Collaborations

4. 9.4. Competitive Dashboard

10. COMPANY PROFILES

1. 10.1. Illumina

2. 10.2. Thermo Fisher Scientific

3. 10.3. Roche Diagnostics

4. 10.4. Agilent Technologies

5. 10.5. QIAGEN

6. 10.6. Bio-Rad Laboratories

7. 10.7. Danaher Corporation

8. 10.8. BGI Genomics

9. 10.9. Oxford Nanopore Technologies

10. 10.10. Pacific Biosciences

11. APPENDIX

1. 11.1. Currency

2. 11.2. Assumptions

3. 11.3. Base and Forecast Years Timeline

4. 11.4. Key benefits for the stakeholders

5. 11.5. Research Methodology

6. 11.6. Abbreviations